EU Authorized Representative for Egypt: From an EDA Licence to MDR Annex II
Egypt has built a real consumables and disposables industry, much of it in the industrial and Suez Canal zones and much of it pointed at European buyers. What it has not built, in most cases, is a technical file that MDR would recognise. The Egyptian Drug Authority's own guidelines make the reason unusually plain: its classification is taken from the repealed Medical Devices Directive, and it publishes a separate registration route for factories that hold no CE certificate at all. This page maps what has to be built and what already exists.
The class on your EDA file was read off a Directive that no longer exists
Start here, because everything else follows from it. The Egyptian Drug Authority’s guideline for locally manufactured devices sets out its classification under the heading "Classification of medical devices according to EU-MDD – Annex IX" (EDA, EDREX:GL.CAMD.010, Section 4), and then lists Class I, Is, Im, IIa, IIb and III. Those are European classes. They are also European classes from the wrong instrument.
Annex IX of Directive 93/42/EEC contained eighteen classification rules. It was repealed and replaced by Annex VIII of Regulation (EU) 2017/745, which contains twenty-two. The four extra rules are not filler: they were written precisely to capture products the Directive under-classified. So an Egyptian manufacturer holding an EDA registration licence for a Class IIa device has a classification that was correct under a repealed Directive and may not survive Annex VIII. This is the most common surprise in an Egyptian file, and it is avoidable if you re-run the rules before commissioning a notified body.
| What your EDA file says | What MDR Annex VIII asks you to re-check |
|---|---|
| Class I, non-sterile | Still class I in most cases — but if the device is a reusable surgical instrument it becomes class Ir, and a notified body must be involved in the reprocessing aspects (MDR Art. 52(7)(c)) |
| Class Is (sterile) | Class Is survives. Notified body involvement is limited to establishing, securing and maintaining sterile conditions (MDR Art. 52(7)(a)) — a narrow audit, but an audit |
| Class Im (measuring) | Class Im survives, with notified body involvement limited to the metrological requirements (MDR Art. 52(7)(b)) |
| Class IIa | Check Rules 19, 20 and 21, which have no Directive equivalent. Devices containing nanomaterials, or composed of substances absorbed by the body, can move sharply upward |
| Class IIb / III | The class may hold, but Article 61 and Annex XIV clinical evidence expectations are materially higher than anything the Directive file was built to satisfy |
Egypt wrote a whole guideline for factories that hold no CE certificate
This is the fact that decides how long an Egyptian project takes, and it comes from the EDA’s own drafting. Alongside the guideline for devices holding international quality certificates, the Authority issued a separate guideline (EDREX:GL.CAMD.010, effective 20 July 2022) whose stated subject is the registration of locally manufactured devices held by factories with ISO 13485:2016 but without a CE certificate.
Read that as a description of the domestic norm. A large share of Egyptian production is registered on a route that was designed on the assumption that no CE certificate exists. The factory is inspected against national technical requirements — drainage, clean-room and air-handling specifications, sterilisation controls — and the file that results is a facility file. It is a real document, produced by real inspection. It is not technical documentation in the sense Annex II uses the term, and translation does not make it one.
Legal manufacturer and actual manufacturer: Egypt already has the words
The EDA guidelines distinguish the legal manufacturer — the entity responsible for designing, manufacturing, packaging and labelling the device before it is placed on the market — from the actual manufacturer that runs the line, and describe an F-Toll arrangement in which one licensed factory registers a device produced by another. Anyone who has worked an EDA file is already fluent in the distinction MDR turns on.
MDR draws the same line and attaches heavier consequences. A manufacturer is "a natural or legal person who manufactures or fully refurbishes a device or has a device designed, manufactured or fully refurbished, and markets that device under its name or trademark" (MDR Art. 2(30)). Whoever puts their name on the device carries Article 10 in full: the quality management system, the technical documentation, the declaration of conformity, post-market surveillance, vigilance. If your Egyptian plant produces to a European buyer’s brand, the buyer is the manufacturer and you are their supplier. If you export under your own brand, you are the manufacturer, and Article 11(1) then requires an authorised representative in a Member State before a single unit is placed on the Union market.
Suez Canal Economic Zone approvals, and the certificate a European buyer wants
Egypt’s device manufacturing sits inside an industrial-policy structure, and the EDA guideline says so: a factory must hold approvals from the Industrial Development Authority, the Investment Authority, or the General Authority for the Suez Canal Economic Zone before its technical file is assessed. Those approvals are the entry ticket to an export-oriented zone, and they do a great deal for logistics into Europe.
They do nothing for conformity. The Union has no reliance mechanism for Egyptian approvals and no route by which an EDA registration licence produces a CE marking. Proximity to European ports is a commercial advantage that arrives with zero regulatory credit — which is why exporters discover the gap late, when a distributor in Italy or Greece asks for the EU declaration of conformity.
Annex II from a standing start: what is usually missing
Building MDR technical documentation on an Egyptian consumables file is a construction project, not a translation project. The elements that are almost always absent, in rough order of effort:
- A general safety and performance requirements checklist worked against Annex I, clause by clause, with the specific evidence or harmonised standard cited for each — not a summary statement of compliance.
- Biological evaluation to EN ISO 10993 for every patient-contacting material, with a rationale that covers colourants, adhesives, lubricants and sterilant residues, not only the base polymer.
- A sterilisation validation package and a shelf-life justification with real-time data started, not accelerated data alone.
- A clinical evaluation under Article 61 and Annex XIV. Equivalence to a competitor device is available in principle but requires contractual access to that device’s technical documentation, which for most consumables is unobtainable.
- A post-market surveillance plan to Annex III, with the periodic safety update report obligation attached for class IIa and above.
- UDI assignment: a Basic UDI-DI per device group and UDI-DIs down to packaging level.
Getting the Union side in place from Cairo, Alexandria or Ain Sokhna
The mandate is short and its effect is not. "Where the manufacturer of a device is not established in a Member State, the device may only be placed on the Union market if the manufacturer designates a sole authorised representative." (MDR Art. 11(1)) The representative must hold a copy of your technical documentation and declaration of conformity at the disposal of competent authorities, answer them in an official Union language, and carry out the registration duties. It must also have "permanently and continuously at their disposal at least one person responsible for regulatory compliance" (MDR Art. 15(6)).
And it must be an EU address on the carton: Annex I, Section 23.2(d) requires the name and registered place of business of the authorised representative on the label of a device whose manufacturer is established outside the Union. Medex holds EUDAMED authorised representative SRN TR-AR-000057550 and works from Ankara, İstanbul and Gdańsk. The mandate and the EUDAMED registrations are the two steps we run.
What Egyptian manufacturers ask when a European buyer asks for CE
We are registered with the EDA. Does that count for anything in Europe?
For conformity, no. An EDA registration licence authorises circulation in Egypt and is not evidence that a device meets the general safety and performance requirements in MDR Annex I. What does carry across is the underlying work: sterilisation validations, biocompatibility testing and process controls generated for the Egyptian file are reusable evidence, provided they were produced to internationally recognised standards.
Our ISO 13485 certificate is from an international body. Is that enough for the quality system?
It is a strong start and it is not a substitute. For any device above class I, a notified body carries out its own quality management system assessment under MDR Annex IX, Chapter I. An existing ISO 13485 certificate makes that audit shorter and less painful; it does not remove it.
Can our European distributor act as our authorized representative?
It can, if it is established in the Union and accepts the mandate in writing, but think about what you are asking of it. Under Article 11(5) the representative becomes legally liable for defective devices jointly and severally with the manufacturer where the manufacturer has not met Article 10. Distributors that understand this usually decline, and the arrangement also blurs the Article 13 and Article 14 duties they already owe.
We produce to a German customer’s brand. Do we still need a representative?
Not for those products. If the device goes to market under the customer’s name and that customer is identified as the manufacturer on the label, the customer carries Article 10 and, being established in the Union, needs no representative. You will still be audited as a critical supplier and named in their technical documentation. If you also sell the same product under your own brand, that line does need its own mandate.